Onceweekly tirzepatide versus oncedaily insulin degludec as addon to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS3): a randomised, openlabel, parallelgroup, phase 3 trial
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): A 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
Water (150 ml) and THF (30 ml) were added to the obtained compound at 25-30C
Some studies suggest that it can help reduce inflammation and improve muscle recovery, which are great benefits for athletes and active individuals
Read: Should You Get a Blood Test for Alzheimers